List of insiders holdings for ACADIA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2023-05-24 17:11:36 | 43,227,599 0 | 43,227,599 | Form 13D |
BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2024-05-31 16:10:16 | 205,752 39,413,587 | 39,619,339 | Form 4 |
GORDON CARL L Director | 2005-04-22 17:16:41 | 0 1,485,512 | 1,485,512 | Form 4 |
NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD Nomura Phase4 Ventures LP Member of 13G Group (1) 10% Owner | 2010-02-12 14:28:15 | 549,752 0 | 549,752 | Form 13G |
Hacksell Uli CEO | 2015-02-19 17:58:47 | 313,500 115,549 | 429,049 | Form 4 |
Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2024-08-13 18:05:04 | 389,126 0 | 389,126 | Form 4 |
Brann Mark R President & CSO | 2006-06-19 16:23:17 | 52,593 317,756 | 370,349 | Form 4 |
Adams Catherine Owen Chief Executive Officer | 2024-09-25 18:53:04 | 353,261 0 | 353,261 | Form 4 |
Williamson Douglas J Executive VP, Research & Dev | 2023-02-13 18:45:02 | 287,951 0 | 287,951 | Form 4 |
DAVIS STEPHEN CEO | 2024-08-20 18:40:42 | 186,555 0 | 186,555 | Form 4 |
Mills Roger EVP, DEVELOPMENT AND CMO | 2015-03-24 18:00:25 | 180,000 0 | 180,000 | Form 4 |
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 2024-02-08 17:09:17 | 152,478 0 | 152,478 | Form 4 |
GRAY MARY ANN Director | 2016-06-09 17:28:57 | 149,476 0 | 149,476 | Form 4 |
Richards Douglas E VP of Business Development | 2004-05-26 21:34:49 | 120,000 0 | 120,000 | Form 3 |
Aasen Thomas H EXEC VP, CFO AND CBO | 2014-04-04 19:51:23 | 106,819 0 | 106,819 | Form 4 |
Stankovic Srdjan R. President | 2022-11-22 16:34:37 | 61,234 0 | 61,234 | Form 4 |
SOLAND DANIEL B Director | 2024-05-31 18:00:10 | 60,000 0 | 60,000 | Form 4 |
Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-08-20 18:43:23 | 52,177 0 | 52,177 | Form 4 |
HARRIGAN EDMUND Director | 2024-05-31 18:00:13 | 51,000 0 | 51,000 | Form 4 |
Daly James M Director | 2024-05-31 18:00:16 | 50,000 0 | 50,000 | Form 4 |
GAROFALO ELIZABETH A. Director | 2024-05-31 18:00:18 | 47,860 0 | 47,860 | Form 4 |
KIM AUSTIN D. EVP,General Counsel, Secretary | 2024-01-09 18:00:29 | 46,901 0 | 46,901 | Form 4 |
Brege Laura Director | 2024-05-31 18:00:07 | 45,500 0 | 45,500 | Form 4 |
WALTON ALAN G Director | 2009-06-16 16:22:08 | 44,722 0 | 44,722 | Form 4 |
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-08-20 18:46:23 | 43,735 0 | 43,735 | Form 4 |
Kaiser John Joseph VP, Strat. Mrkting & Com. Dev. | 2008-10-22 19:38:07 | 40,000 0 | 40,000 | Form 4 |
Iversen Leslie L Director | 2016-04-20 17:37:28 | 36,127 0 | 36,127 | Form 4 |
Tolf Bo-Ragnar VP/Mg. Dir. ACADIA Pharma AB | 2009-07-09 16:39:38 | 35,000 0 | 35,000 | Form 4 |
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | 2017-03-10 20:37:19 | 33,750 0 | 33,750 | Form 4 |
Davis Robert E Exec. VP, Drug Discovery | 2005-03-15 20:52:26 | 30,000 0 | 30,000 | Form 4 |
Baity Glenn EVP AND GC | 2018-04-20 18:37:24 | 28,125 0 | 28,125 | Form 4 |
YOUNG TODD S. EVP AND CFO | 2018-10-24 16:27:12 | 23,438 0 | 23,438 | Form 4 |
Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-05-03 18:00:40 | 22,158 0 | 22,158 | Form 4 |
Ridloff Elena EVP and CFO | 2021-04-30 18:55:12 | 17,044 0 | 17,044 | Form 4 |
KAPLAN LESTER J PH D Director | 2015-08-13 17:10:12 | 17,000 0 | 17,000 | Form 4 |
YANG MICHAEL J. EVP and CCO | 2021-01-08 19:31:12 | 16,226 0 | 16,226 | Form 4 |
Lundstrom Brian Sr. VP, Bus. Development | 2008-03-11 20:06:11 | 16,000 0 | 16,000 | Form 4 |
Ndu Adora Director | 2024-10-15 18:05:05 | 15,414 0 | 15,414 | Form 4 |
Wells William McDowall Director | 2015-06-17 19:11:56 | 12,500 0 | 12,500 | Form 4 |
Rasmussen Torsten Director | 2015-06-17 19:10:36 | 0 12,500 | 12,500 | Form 4 |
BORER MICHAEL T Director | 2015-06-17 19:06:59 | 12,500 0 | 12,500 | Form 4 |
van Osch Martien Director | 2005-06-14 16:37:12 | 11,584 0 | 11,584 | Form 4 |
Binder Gordon M Director | 2009-06-16 16:05:13 | 10,000 0 | 10,000 | Form 4 |
Miller Eric Alejandro Controller & PAO | 2019-10-17 18:26:38 | 1,524 0 | 1,524 | Form 4 |
Biggar Stephen R Director | 2013-01-23 16:41:51 | 0 0 | 0 | Form 3 |
OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G 10% Owner | 2011-02-14 10:32:00 | 0 0 | 0 | Form 13G |